You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
The new era of nanotechnology, an alternative to change cancer treatment
|
|---|---|
| Published in |
Drug Design, Development and Therapy, September 2017
|
| DOI | 10.2147/dddt.s142337 |
| Pubmed ID | |
| Authors |
Ancuta Jurj, Cornelia Braicu, Laura-Ancuta Pop, Ciprian Tomuleasa, Claudia Diana Gherman, Ioana Berindan-Neagoe |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Italy | 1 | 17% |
| Netherlands | 1 | 17% |
| Unknown | 4 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
| Scientists | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 216 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 216 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 38 | 18% |
| Student > Bachelor | 30 | 14% |
| Student > Master | 25 | 12% |
| Researcher | 12 | 6% |
| Student > Doctoral Student | 7 | 3% |
| Other | 25 | 12% |
| Unknown | 79 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 33 | 15% |
| Pharmacology, Toxicology and Pharmaceutical Science | 31 | 14% |
| Medicine and Dentistry | 16 | 7% |
| Agricultural and Biological Sciences | 14 | 6% |
| Chemistry | 9 | 4% |
| Other | 25 | 12% |
| Unknown | 88 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 September 2018.
All research outputs
#7,480,508
of 26,017,215 outputs
Outputs from Drug Design, Development and Therapy
#483
of 2,296 outputs
Outputs of similar age
#108,108
of 328,416 outputs
Outputs of similar age from Drug Design, Development and Therapy
#9
of 49 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 2,296 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,416 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.